CareLit · DOI-Nachweis · Pneumologie
Epidermal Fatty Acid-Binding Protein (E-FABP) is increased in rat lungs following in vivo treatment with Keratinocyte Growth Factor (KGF)
DOI 10.1055/s-2005-925498
Bibliografische Angaben
Nachweis in CareLit
Autor:innenV Grau, H Garn, J Holler, F Rose, S Blöcher, M Hirschburger, H Fehrenbach, W Padberg
ZeitschriftPneumologie
Ausgabe01/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Exogenous application of Keratinocyte Growth Factor (KGF) protects the lung against a variety of injurious stimuli. KGF-treatment leads to pronounced hyperplasia of alveolar epithelial type II cells and to stabilization of surfactant homeostasis after lung injury. Epidermal Fatty Acid-Binding Protein (E-FABP) is involved in the synthesis of surfactant phospholipids and acts as an antioxidant scavenging reactive lipi…
Zitieren
Zitierempfehlung
V Grau, H Garn, J Holler, F Rose, S Blöcher, M Hirschburger, H Fehrenbach, W Padberg (2006) Epidermal Fatty Acid-Binding Protein (E-FABP) is increased in rat lungs following in vivo treatment with Keratinocyte Growth Factor (KGF). Pneumologie (01). https://doi.org/10.1055/s-2005-925498
Mit CareLit weiterarbeiten